Pharmacoeconomics and Policy2026，Vol.2Issue(1)：P.4-11,8.DOI:10.1016/j.pharp.2026.03.002
Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention:A systematic review
Saba Abidi 1Shridhar Dwivedi 2Vinod Sharma 2Anoop Kumar 3Sushama Talegaonkar4
作者信息
- 1. School of Allied Health Sciences and Management,Delhi Pharmaceutical Sciences and Research University,New Delhi 110017,India
- 2. National Heart Institute,New Delhi 110065,India
- 3. Department of Pharmacology,Delhi Pharmaceutical Sciences and Research University,New Delhi 110017,India
- 4. Department of Pharmaceutics,School of Pharmaceutical Sciences,Delhi Pharmaceutical Sciences and Research University,New Delhi 110017,India
- 折叠
摘要
关键词
Acute coronary syndrome/Antiplatelet/Clopidogrel/Cost‑effectiveness/Economic evaluation/Percutaneous coronary intervention/Systematic review分类
医药卫生引用本文复制引用
Saba Abidi,Shridhar Dwivedi,Vinod Sharma,Anoop Kumar,Sushama Talegaonkar..Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention:A systematic review[J].Pharmacoeconomics and Policy,2026,2(1):P.4-11,8.
